Procedure for Stability Testing of High-Risk Drug Products

1) Purpose

The purpose of this SOP is to establish a procedure for conducting stability testing of high-risk drug products in compliance with relevant regulatory guidelines. This ensures that these products maintain their safety, efficacy, and quality throughout their shelf life.

2) Scope

This SOP applies to all personnel involved in the stability testing of high-risk drug products, including quality control, product development, and regulatory affairs teams.

3) Responsibilities

Formulation Development Team: Responsible for developing high-risk drug formulations and selecting suitable packaging.
Stability Study Team: Responsible for conducting stability studies according to approved protocols.
Regulatory Affairs Team: Responsible for ensuring compliance with regulatory requirements.

4) Procedure

4.1 Protocol Development

4.1.1 Develop a stability testing protocol that addresses the unique risks associated with the product, such as potential degradation or contamination.

4.1.2 Include storage conditions and testing intervals according to

regulatory guidelines.

4.2 Sample Preparation and Storage

4.2.1 Prepare samples in their final packaging.

4.2.2 Store samples under specified conditions to simulate real-world use scenarios.

4.3 Conducting Stability Tests

4.3.1 Perform stability tests at all required intervals.

4.3.2 Record all data accurately and document any deviations.

4.4 Data Analysis and Reporting

4.4.1 Analyze the stability data to assess any changes